Muscle Atrophy Clinical Trials

Find Muscle Atrophy Clinical Trials Near You

Reference Values for Lower-Limb Dynamometry in Patients With Chronic Kidney Disease (REHAD-CKD)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Patients with chronic kidney disease (CKD) undergoing hemodialysis present musculoskeletal complications, such as sarcopenia, which impair their functionality and are associated with an increased risk of mortality. Functional assessment in this population is complex due to the organization of hemodialysis schedules and patients' dependence on medical transportation, which hinders evaluation outside the dialysis setting. The assessment of lower limb strength is of great relevance, as an adequate level of muscle strength in this region is essential for performing many activities of daily living, including walking, sit-to-stand and stand-to-sit movements, as well as ascending and descending stairs. Our research group has published a study demonstrating the safety and reliability of intradialytic measurement of hip flexion and abduction strength; however, reference values for the dialysis population and for individuals with CKD in general are currently unknown. The primary aim of this study is to propose reference values for hip flexor and abductor muscle strength measured using a hand-held dynamometer in individuals with chronic kidney disease (CKD). Secondary objectives include assessing the association between lower limb muscle strength measured with a hand-held dynamometer and handgrip strength, physical activity level, frailty, gait speed, performance in the 10-repetition sit-to-stand-to-sit test, ultrasound assessment of the rectus femoris muscle, and health-related quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• ≥1 months on HD (3 weekly sessions of 4 hours)

Locations
Other Locations
Spain
Diaverum Madrid
RECRUITING
Madrid
Contact Information
Primary
Eva Ms Segura Ortí, Professor
esegura@uchceu.es
+34671580094
Time Frame
Start Date: 2026-10
Estimated Completion Date: 2026-12
Participants
Target number of participants: 50
Treatments
REHAB-CKD group
The target population of the present study consists of patients with chronic kidney disease undergoing hemodialysis in DIAVERUM centers in Spain.
Related Therapeutic Areas
Sponsors
Leads: Cardenal Herrera University
Collaborators: Medizinisches Versorgungszentrum Diaverum Potsdam

This content was sourced from clinicaltrials.gov